MXPA03000276A - Nueva formulacion en aerosol que contiene una molecula fluorada polar. - Google Patents

Nueva formulacion en aerosol que contiene una molecula fluorada polar.

Info

Publication number
MXPA03000276A
MXPA03000276A MXPA03000276A MXPA03000276A MXPA03000276A MX PA03000276 A MXPA03000276 A MX PA03000276A MX PA03000276 A MXPA03000276 A MX PA03000276A MX PA03000276 A MXPA03000276 A MX PA03000276A MX PA03000276 A MXPA03000276 A MX PA03000276A
Authority
MX
Mexico
Prior art keywords
aerosol formulation
formulation containing
polar fluorinated
novel aerosol
fluorinated molecule
Prior art date
Application number
MXPA03000276A
Other languages
English (en)
Inventor
Philippe Rogueda
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA03000276A publication Critical patent/MXPA03000276A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

La presente invencion se refiere a una formulacion en aerosol farmacéutica, estable, propuesta para inhalacion. La formulacion contiene una substancia activa, un propulsor en aerosol, una molécula fluorada polar y un excipiente. El propulsor preferido es HFA 134a o HFA 227 o una mezcla de los mismos.
MXPA03000276A 2000-07-11 2001-07-10 Nueva formulacion en aerosol que contiene una molecula fluorada polar. MXPA03000276A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016876.5A GB0016876D0 (en) 2000-07-11 2000-07-11 Novel formulation
PCT/SE2001/001606 WO2002003958A1 (en) 2000-07-11 2001-07-10 Novel aerosol formulation containing a polar fluorinated molecule

Publications (1)

Publication Number Publication Date
MXPA03000276A true MXPA03000276A (es) 2003-06-06

Family

ID=9895336

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000276A MXPA03000276A (es) 2000-07-11 2001-07-10 Nueva formulacion en aerosol que contiene una molecula fluorada polar.

Country Status (21)

Country Link
US (1) US20030194378A1 (es)
EP (1) EP1303258B1 (es)
JP (1) JP2004502719A (es)
KR (1) KR20030025265A (es)
CN (1) CN1455663A (es)
AT (1) ATE342048T1 (es)
AU (2) AU2001272866B2 (es)
BR (1) BR0112322A (es)
CA (1) CA2415092A1 (es)
CY (1) CY1105913T1 (es)
DE (1) DE60123793T2 (es)
DK (1) DK1303258T3 (es)
ES (1) ES2273864T3 (es)
GB (1) GB0016876D0 (es)
IL (2) IL153726A0 (es)
MX (1) MXPA03000276A (es)
NO (1) NO20030133L (es)
NZ (1) NZ523379A (es)
PT (1) PT1303258E (es)
WO (1) WO2002003958A1 (es)
ZA (1) ZA200300075B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759042A (ja) * 1993-08-13 1995-03-03 Toshiba Corp 画像保管装置
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1453524A2 (en) * 2001-12-04 2004-09-08 Minnesota High-Tech Resources, LLC Breathable gas mixtures to change body temperature
CA2470520A1 (en) 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
EP1474118A1 (en) * 2002-02-01 2004-11-10 AstraZeneca AB Composition for inhalation
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
FR2851166A1 (fr) * 2003-02-13 2004-08-20 D Lab Utilisation d'un liquide volatil a pression atmospherique et a temperature ambiante pour la fabrication de compositions pharmaceutiques et/ou biologiques
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060188729A1 (en) * 2005-02-22 2006-08-24 Kai-Volker Schubert Washable leather with repellency
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US20090012250A1 (en) * 2007-07-03 2009-01-08 Yu-Chin Lai Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
KR100910848B1 (ko) * 2007-09-13 2009-08-06 재단법인서울대학교산학협력재단 알러지성 비염 치료약물을 유효성분으로 함유하는 비강분무용 마이크로스피어 및 이의 제조방법
WO2009052519A2 (en) * 2007-10-19 2009-04-23 Wayne State University Co-polymer stabilizers for hydrofluoroalkane dispersions
WO2009133575A1 (en) * 2008-04-28 2009-11-05 Al.Chi.Mi.A. S.R.L. Fluoroalkyloxy alkanes, process for production and uses thereof
EP2459182B1 (en) * 2009-07-30 2017-09-06 University of Zürich Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
JP5639069B2 (ja) * 2009-10-09 2014-12-10 株式会社クレハ 新規なフッ化ビニリデン共重合体及びその製造方法
EP2407150A1 (de) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Nano- und Mikropolymerpartikel zur Aufrechterhaltung einer niedrigen Oberflächenspannung in der Lunge und zum Schutz des pulmonalen Surfactants
WO2014012661A1 (de) * 2012-07-18 2014-01-23 Merck Patent Gmbh Fluortenside
KR101516057B1 (ko) * 2012-12-07 2015-04-30 가톨릭대학교 산학협력단 폐질환 치료용 흡입 제형 및 이의 제조방법
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
US20200306171A1 (en) * 2019-04-01 2020-10-01 Honeywell International Inc. Personal care aerosol compositions, methods and devices

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557294A (en) * 1967-10-12 1971-01-19 Allied Chem Fluorinated ethers as inhalation convulsants
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
US5605882A (en) * 1992-05-28 1997-02-25 E. I. Du Pont De Nemours And Company Azeotrope(like) compositions of pentafluorodimethyl ether and difluoromethane
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
JP3573213B2 (ja) * 1995-04-14 2004-10-06 グラクソ、ウェルカム、インコーポレーテッド ベクロメタゾンジプロピオネート用計量投与用吸入器
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5730894A (en) * 1996-04-16 1998-03-24 E. I. Du Pont De Nemours And Company 1,1,2,2,3,3,4,4-octafluorobutane azeotropic (like) compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP2001511160A (ja) * 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
ZA200300075B (en) 2004-04-05
NO20030133D0 (no) 2003-01-10
US20030194378A1 (en) 2003-10-16
CN1455663A (zh) 2003-11-12
ATE342048T1 (de) 2006-11-15
AU2001272866B2 (en) 2005-08-11
PT1303258E (pt) 2007-01-31
NO20030133L (no) 2003-02-24
BR0112322A (pt) 2003-07-08
EP1303258A1 (en) 2003-04-23
IL153726A0 (en) 2003-07-06
DE60123793T2 (de) 2007-09-06
WO2002003958A1 (en) 2002-01-17
JP2004502719A (ja) 2004-01-29
EP1303258B1 (en) 2006-10-11
NZ523379A (en) 2004-06-25
ES2273864T3 (es) 2007-05-16
DK1303258T3 (da) 2007-01-22
CY1105913T1 (el) 2011-04-06
DE60123793D1 (de) 2006-11-23
IL153726A (en) 2008-07-08
AU7286601A (en) 2002-01-21
KR20030025265A (ko) 2003-03-28
GB0016876D0 (en) 2000-08-30
CA2415092A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
IL153726A0 (en) Novel aerosol formulation containing a polar fluorinated molecule
NZ509328A (en) Medicinal aerosol formulations
AU2003244450A1 (en) Formulations for inhalation
PT1014943E (pt) Formulacoes medicinais de aerossois
DE69208660T2 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
MXPA03000442A (es) Una formulacion medicinal en aerosol.
HUP0002691A2 (hu) Ciklezonid tartalmú gyógyászati aeroszol termékek
AP2000001961A0 (en) Pharmaceutical aerosol formulation.
GB2354007B (en) Pharmaceutical formulation of fluticasone propionate
ATE233084T1 (de) Pharmazeutische aerosolformulierung
BR9712125A (pt) Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
EP1523976A3 (en) Pharmaceutical formulations of salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
TH29519B (th) สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน

Legal Events

Date Code Title Description
FG Grant or registration